Synthesis, biological activity, QSAR and QSPR study of 2- aminobenzimidazole derivatives as potent H3-antagonists

Bioorganic and Medicinal Chemistry

Volumn 12, Issue 4, 2004, Pages 663-674

  Mor, Marco ^a   Bordi, Fabrizio ^a   Silva, Claudia ^a   Rivara, Silvia ^a   Zuliani, Valentina ^a   Vacondio, Federica ^a   Rivara, Mirko ^a   Barocelli, Elisabetta ^a   Bertoni, Simona ^a   Ballabeni, Vigilio ^a   Magnanini, Francesca ^a   Impicciatore, Mariannina ^a   Plazzi, Pier Vincenzo ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

2 aminobenzimidazole; H3 receptor antagonists; Histamine; QSAR

Indexed keywords

BENZIMIDAZOLE DERIVATIVE; HISTAMINE H3 RECEPTOR ANTAGONIST;

ALKALINITY; ARTICLE; CORRELATION ANALYSIS; DRUG ACTIVITY; DRUG SYNTHESIS; ELECTRONICS; EVALUATION; LIPOPHILICITY; MULTIPLE REGRESSION; QUANTITATIVE STRUCTURE ACTIVITY RELATION; QUANTITATIVE STRUCTURE PROPERTY RELATION; RECEPTOR AFFINITY; RECEPTOR BINDING; STEREOCHEMISTRY;

CAVIA PORCELLUS; SUS SCROFA;

EID: 0842283496     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2003.11.030     Document Type: Article

References (62)

1. Hill S.J., Ganellin C.R., Timmerman H., Schwartz J.-C., Shankley N.P., Young J.M., Schunack W., Levi R., Haas H.L. Pharmacol. Rev. 49:1997;253.
2. Nakamura T., Itadani H., Hidaka Y., Ohta M., Tanaka K. Biochem. Biophys. Res. Commun. 279:2000;615.
3. Arrang J.-M., Garbarg M., Schwartz J.-C. Nature (London). 302:1983;832.
4. Lovenberg T.W., Pyaty J., Chang H., Wilson S.J., Erlander M.G. J. Pharm. Exp. Ther. 293:2000;771.
5. Arrang J.-M., Garbarg M., Schwartz J.-C. Neuroscience. 15:1985;553.
6. Arrang J.-M., Deveaux B., Chodkiewicz J.-P., Schwartz J.-C. J. Neurochem. 51:1988;105.
7. Molderings G.J., Weibenborn G., Schlicker E., Likungu J., Göthert M. Naunyn-Schmiedeberg's Arch. Pharmacol. 346:1992;46.
8. Clapham J., Kilpatrick G.J. Br. J. Pharmacol. 107:1992;919.
9. Schlicker E., Fink K., Detzner J., Göthert M. J. Neural. Transm. 93:1993;1.
10. Schlicker E., Betz R., Göthert M. Arch. Pharmacol. 337:1988;588.
11. Philippu A., Prast H. Behav. Brain Res. 124:2001;151.
12. Baciottini L., Passani M.B., Mannaioni P.F., Blandina P. Behav. Brain Res. 124:2001;183.
13. Lipp O.R., Stark H., Schunack W. Recept. Biochem. Methodol. 16:1992;57.
14. Arrang J.-M., Garbarg M., Lancelot J.C., Lecomte J.M., Pollard H., Robba M., Schunack W., Schwartz J.-C. Nature. 327:1987;117.
15. Van der Goot H., Schepers M.J.P., Sterk G.J., Timmerman H. Eur. J. Med. Chem. 27:1992;511.
16. Jansen F.P., Wu T.S., Voss H.-P., Steinbusch H.W.M., Vollinga R.C., Rademaker B., Bast A., Timmerman H. Br. J. Pharmacol. 113:1994;355.
17. Stark H., Krause M., Arrang J.-M., Ligneau X., Schwartz J.-C., Schunack W. Bioorg. Med. Chem. Lett. 4:1994;2907.
18. Reidemeister S., Stark S., Ligneau X., Ganellin C.R., Schwartz J.-C., Schunack W. Pharmazie. 55:2000;83.
19. Tozer M.J., Buck I.M., Cooke T., Kalindjian S.B., Pether M.J., Steel K.I. Bioorg. Med. Chem. Lett. 10:2002;425.
20. Clitherow J.W., Beswick P., Irving W.J., Scopes D.I.C., Barnes J.C., Clapham J., Brown J.D., Evans D.J., Hayes A.G. Bioorg. Med. Chem. Lett. 6:1996;833.
21. Ganellin C.R., Hosseini S.K., Khalaf Y.S., Tertiuk W., Arrang J.-M., Garbarg M., Ligneau X., Schwartz J.-C. J. Med. Chem. 38:1995;3342.
22. Plazzi P.V., Bordi F., Mor M., Silva C., Morini G., Caretta A., Barocelli E., Vitali T. Eur. J. Med. Chem. 30:1995;881.
23. Barocelli E., Ballabeni V., Caretta A., Chiavarini M., Bordi F., Mor M., Impicciatore M. Pharm. Sci. 1:1995;383.
24. Mor M., Bordi F., Silva C., Rivara S., Crivori P., Plazzi P.V., Ballabeni V., Caretta A., Barocelli E., Impicciatore M., Carrupt P.-A., Testa B. J. Med. Chem. 40:1997;2571.
25. Mor M., Bordi F., Silva C., Rivara S., Zuliani V., Vacondio F., Morini G., Barocelli E., Ballabeni V., Impicciatore M., Plazzi P.V. Farmaco. 55:2000;27.
26. Mikò T., Ligneau X., Pertz H.H., Ganellin C.R., Arrang J.-M., Schwartz J.-C., Schunack W., Stark H. J. Med. Chem. 46:2003;1523.
27. Turner S.C., Esbenshade T.A., Bennani Y.L., Hancock A.A. Bioorg. Med. Chem. Lett. 13:2003;2131.
28. Apodaca R., Dvorak C.A., Xiao W., Barbier A.J., Boggs J.D., Wilson S.J., Lovenberg T.W., Carruthers N.I. J. Med. Chem. 46:2003;3938.
29. Stark H., Sadek B., Krause M., Hüls A., Ligneau X., Ganellin C.R., Arrang J.-M., Schwartz J.-C., Schunack W. J. Med. Chem. 43:2000;3987.
30. Sasse A., Sadek B., Ligneau X., Elz S., Pertz H.H., Luger P., Ganellin C.R., Arrang J.-M., Schwartz J.-C., Schunack W., Stark H. J. Med. Chem. 43:2000;3335.
31. Ali S.A., Tedford C.E., Gregory R., Handley M.H., Yates S.L., Hirth W.W., Phillips J.G. J. Med. Chem. 42:1999;903.
32. Stark H., Ligneau X., Arrang J.-M. ., Schwartz J.-C., Schunack W. Bioorg. Med. Chem. Lett. 8:1998;2011.
33. Serafino A., Sorba G., Daniele P.G. Annali di Chimica. 79:1989;81.
34. Skagerberg B., Bonelli D., Clementi S., Cruciani G., Ebert C. Quant. Struct.-Act. Relat. 8:1989;32.
35. Tomioka H., Ichikawa N., Komatsu K. J. Am. Chem. Soc. 114:1992;8045.
36. Clark R.L., Pessolano A.A. J. Am. Chem. Soc. 80:1958;1657.
37. Kumar S., Seth M., Bhaduri A.P., Visen P.K.S., Misra A., Gupta S., Fatima N., Katiyar J.C., Chatterjce R.K., Sen A.B. J. Med. Chem. 27:1984;1083.
38. Silk J.A. J. Chem. Soc., part II. 1956;2058.
39. Keana J.F.W., Kher S.M., Cai S.X., Dinsmore C.M., Glenn A.G., Guastella J., Huang J.-C., Ilyin V., Lü Y., Mouser P.L., Woodward R.M., Weber E. J. Med. Chem. 38:1995;4367.
40. Cai S.X., Kher S.M., Zhou Z.-L., Ilyin V., Espitias S.A., Tran M., Hawkinson J.E., Woodward R.M., Weber E., Keana F.W. J. Med. Chem. 40:1997;730.
41. Göker H., Ertan R. Arch. Pharm. (Weinheim). 324:1991;283.
42. Sorba G., Garrone A., Serafino A., Gasco A., Orsetti M. Eur. J. Med. Chem.-Chim. Ther. 21:1986;391.
43. Vollinga R.C., Menge W.M.P.B., Timmerman H. Recl. Trav. Chim. Pays-Bas. 112:1993;123.
44. Barocelli E., Ballabeni V., Caretta A., Bordi F., Silva C., Morini G., Impicciatore M. Agents Actions. 38:1993;158.
45. a Prediction for Organic Acids and Bases; Chapman and Hall: London and New York, 1981; pp 17-18.
46. van de Waterbeemd, H; Testa, B. In: Advances in Drug Research; Testa, B. (Ed.), Academic Press: London, 1987; Vol. 16, pp 85-225.
47. Hansch, C.; Leo, A.; Hoekman, D. In: Exploring QSAR - Hydrophobic, Electronic and Steric Constants; American Chemical Society: Washington, DC, 1995.
48. Avdeef, A. In: Lipophilicity in Drug Action and Toxicology; Pliska, V., Testa, B., van de Waterbeemd, H. (Eds.), VCH: Weinheim, 1996; pp 109-139.
49. Wold S. In: Chemometric Methods in Molecular Design; van de Waaterbeemd, H. (Ed.), VCH Publishers Inc.: New York, 1995; pp 195-218.
50. Uchida M., Morita S., Chihiro M., Kanbe T., Yamasaki K., Yabuuchi Y., Nakagawa K. Chem. Pharm. Bull. 37:1989;1517.
51. Lavagnino E.R., Thompson D.C. J. Heterocycl. Chem. 9:1972;149.
52. Rao K.V.B., Charles E.S., Sharma S., Iyer R.N., Gupta S., Katiyar C. Eur. J. Med. Chem.-Chim. Ther. 16:1981;35.
53. Gans P., Sabatini A., Vacca A. J. Chem. Soc. Dalton Trans. 6:1985;1195.
54. Cheng Y.C., Prusoff W.H. Biochem. Pharmacol. 22:1973;3099.
55. Furchgott, R.F. In: Handbook of Experimental Pharmacology; Blanschko, E., Muscholl, E. (Eds), Springer: Berlin, 1972; Vol. 33, pp 283-335.
56. Nickel T., Bauer U., Schlicker E., Kathmann M., Gothert M., Sasse A., Stark H., Schunack W. Br. J. Pharmacol. 132:2001;1665.
57. Laitinen J.T., Jokinen M. J. Neurochem. 71:1998;808.
58. Moore R.J., Xiao R., Sim-Selley L.J., Childers S.R. Neuropharmacology. 39:2000;282.
59. Bradford M.M. Anal. Biochem. 72:1976;248.
60. Clark E.A., Hill S.J. Eur. J. Pharmacol. 296:1996;223.
61. Simca-S 6.01, Umetri AB & Ericsson AB, 1997.
62. Wold, S.; Eriksson, L. In: Chemometric Methods in Molecular Design; van de Waaterbeemd, H. (Ed.), VCH Publishers Inc.: New York, 1995; pp 309-318.